Andreessen Horowitz

Hippocratic AI specializes in developing large language models focused on safety and patient-facing applications within the healthcare sector. Unlike common approaches that rely heavily on internet data, Hippocratic AI prioritizes acquiring evidence-based healthcare content legally to ensure accurate and reliable information.

Levels develops a health and wellness platform that monitors metabolic fitness by tracking blood glucose in real time, enabling users to optimize their diet and exercise. The company offers a wellness wearable device paired with a platform that provides real-time feedback on how the body responds to dietary and lifestyle choices, helping users tailor their routines to personal goals. Founded in 2019, Levels operates as a remote-first company focused on helping individuals understand their metabolism to improve health outcomes.

Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

Pomelo Care specializes in evidence-based maternity care, supporting women from preconception through their infant's first year. It offers a unique blend of virtual, round-the-clock clinical care and in-person doula support, addressing medical, behavioral, and social factors to improve maternal and infant health outcomes.

Valar Labs, founded in 2021 by Anirudh Joshi, Viswesh Krishna, Pranav Rajpurkar, and Damir Vrabac, is a healthcare technology company focused on enhancing cancer treatment through the use of artificial intelligence. The company has developed a software platform that analyzes imaging data, which is routinely collected in clinical settings, to provide oncologists with interpretable and actionable insights. By leveraging patient-specific characteristics, Valar Labs aims to support oncologists in making informed treatment decisions, ultimately improving patient outcomes in cancer care.

Hippocratic AI specializes in developing large language models focused on safety and patient-facing applications within the healthcare sector. Unlike common approaches that rely heavily on internet data, Hippocratic AI prioritizes acquiring evidence-based healthcare content legally to ensure accurate and reliable information.

Inductive Bio develops a machine learning platform that accelerates compound optimization for pharmaceutical research. It focuses on building datasets and ML models to predict absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of small molecules, enabling scientists to optimize initial compounds into leads and development candidates more efficiently.

MedScout is a revenue acceleration platform tailored for medical device and diagnostic companies. It offers a sales enablement software that integrates medical claims intelligence from both public and private payors, providing a user-friendly interface specifically designed for sales professionals and leaders. The platform delivers immediate insights into the addressable market within existing territories and facilitates understanding of market dynamics. By supplying comprehensive information on patient demographics, procedure volumes, referral patterns, and payment data, MedScout empowers its clients to optimize their sales strategies and enhance operational productivity, ultimately driving growth in the life sciences sector.

Pomelo Care specializes in evidence-based maternity care, supporting women from preconception through their infant's first year. It offers a unique blend of virtual, round-the-clock clinical care and in-person doula support, addressing medical, behavioral, and social factors to improve maternal and infant health outcomes.

Hippocratic AI specializes in developing large language models focused on safety and patient-facing applications within the healthcare sector. Unlike common approaches that rely heavily on internet data, Hippocratic AI prioritizes acquiring evidence-based healthcare content legally to ensure accurate and reliable information.

Marker Learning specializes in telepsychology services, offering remote assessments for learning disabilities. Their platform provides accessible evaluations by licensed psychologists, serving children and adults up to age 50. They deliver personalized action plans to support individuals with learning disabilities.

Levels develops a health and wellness platform that monitors metabolic fitness by tracking blood glucose in real time, enabling users to optimize their diet and exercise. The company offers a wellness wearable device paired with a platform that provides real-time feedback on how the body responds to dietary and lifestyle choices, helping users tailor their routines to personal goals. Founded in 2019, Levels operates as a remote-first company focused on helping individuals understand their metabolism to improve health outcomes.

Founded in 2016, Firefly Health delivers AI-driven virtual-first primary care. Its platform connects patients with healthcare professionals for convenient, continuous care, focusing on common conditions and women's health issues.

Cipher Skin Inc. is a technology company based in Denver, Colorado, founded in 2014. The company specializes in wearable technology that utilizes innovative mesh sensors to conform to the human body, enabling precise measurement and monitoring of vital data. Cipher Skin's platform captures three-dimensional motion data and biosignals, such as heart rate and oxygen saturation, without the need for cameras or bulky equipment. This technology provides actionable insights that can be trusted, allowing physical therapists and trainers to develop safe and effective programs by accurately assessing complex movements, particularly in the upper limbs. Through its advancements, Cipher Skin aims to create the largest and most accurate data DNA platform of the physical world.

Founded in 2018, Tomorrow Health operates an online marketplace for medical supplies and equipment. It connects providers, health plans, and suppliers to ensure patients receive necessary products and care at home.

Ultima Genomics is a biotechnology company established in 2016 and headquartered in Newark, California. It specializes in genome-scale sequencing technology, focusing on providing analytical services to various enterprises. By employing an open substrate, Ultima Genomics creates a vast, low-cost reaction surface that facilitates billions of reads without relying on expensive flow cells or complex fluidic systems. The company utilizes specialized sequencing hardware combined with machine learning techniques to ensure reproducible and accurate results. This innovative approach enables clients to obtain genomic reports at scale, enhancing the speed and efficiency of sequencing while significantly reducing costs. Ultima Genomics aims to harness the potential of genomic information to drive advancements in biology and improve human health.

Deepcell, Inc. is a biotechnology company based in Mountain View, California, that specializes in single-cell analysis technology. Founded in 2015, the company has developed an AI-powered imaging and microfluidics platform that offers a non-invasive method for genetic testing with diagnostic-level accuracy. This platform enables researchers to classify and isolate viable cells based on their morphological characteristics, thus facilitating improved diagnosis and treatment of diseases. By providing detailed genetic health information through ordinary blood samples, Deepcell aims to enhance translational research, diagnostic testing, and therapeutic applications, ultimately reducing the need for invasive procedures in medical diagnostics.

Topography Health facilitates private practice physicians' involvement in clinical trials. It assists practices in understanding patient populations, recommends suitable studies, recruits patients, and manages research staff, making personalized clinical trials more accessible.

Sprinter Health is a mobile healthcare provider that sends full-time nurses and phlebotomists to patients' homes for preventive care services.

Pomelo Care specializes in evidence-based maternity care, supporting women from preconception through their infant's first year. It offers a unique blend of virtual, round-the-clock clinical care and in-person doula support, addressing medical, behavioral, and social factors to improve maternal and infant health outcomes.

Founded in 2018, Tomorrow Health operates an online marketplace for medical supplies and equipment. It connects providers, health plans, and suppliers to ensure patients receive necessary products and care at home.

Founded in 2016, Firefly Health delivers AI-driven virtual-first primary care. Its platform connects patients with healthcare professionals for convenient, continuous care, focusing on common conditions and women's health issues.

Komodo Health is a healthcare technology company that provides a data-driven platform for real-world health information and insights. Its Healthcare Map aggregates diverse patient data to enable real-time intelligence across patients, clinicians, and health systems. The software suite includes Aperture, Pulse, and Serenity, which reveal intricate connections, highlight opportunities to influence disease burden, and analyze patient cohorts to generate actionable insights. The platform applies artificial intelligence and advanced data science to deliver patient-level analytics to life sciences companies, payers, providers, and other stakeholders. By delivering transparency and market intelligence, Komodo Health supports decision-making aimed at closing care gaps, reducing disease burden, and enabling more value-driven care. The company was founded in 2014 and is headquartered in New York with an additional office in San Francisco.

Deepcell, Inc. is a biotechnology company based in Mountain View, California, that specializes in single-cell analysis technology. Founded in 2015, the company has developed an AI-powered imaging and microfluidics platform that offers a non-invasive method for genetic testing with diagnostic-level accuracy. This platform enables researchers to classify and isolate viable cells based on their morphological characteristics, thus facilitating improved diagnosis and treatment of diseases. By providing detailed genetic health information through ordinary blood samples, Deepcell aims to enhance translational research, diagnostic testing, and therapeutic applications, ultimately reducing the need for invasive procedures in medical diagnostics.

Levels develops a health and wellness platform that monitors metabolic fitness by tracking blood glucose in real time, enabling users to optimize their diet and exercise. The company offers a wellness wearable device paired with a platform that provides real-time feedback on how the body responds to dietary and lifestyle choices, helping users tailor their routines to personal goals. Founded in 2019, Levels operates as a remote-first company focused on helping individuals understand their metabolism to improve health outcomes.

FidoCure develops AI-driven precision medicine for canine cancer. It analyzes data from naturally occurring canine tumors using next-generation sequencing and clinical information to build a proprietary learning database for cancer analysis. The company provides genomic sequencing services and targeted therapy recommendations to veterinarians, enabling personalized treatment plans. By linking veterinary and human oncology, FidoCure advances comparative oncology, aims to improve outcomes for dogs and to inform drug development that benefits both pets and people.

Topography Health facilitates private practice physicians' involvement in clinical trials. It assists practices in understanding patient populations, recommends suitable studies, recruits patients, and manages research staff, making personalized clinical trials more accessible.

Founded in 2018, Tomorrow Health operates an online marketplace for medical supplies and equipment. It connects providers, health plans, and suppliers to ensure patients receive necessary products and care at home.

Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

Komodo Health is a healthcare technology company that provides a data-driven platform for real-world health information and insights. Its Healthcare Map aggregates diverse patient data to enable real-time intelligence across patients, clinicians, and health systems. The software suite includes Aperture, Pulse, and Serenity, which reveal intricate connections, highlight opportunities to influence disease burden, and analyze patient cohorts to generate actionable insights. The platform applies artificial intelligence and advanced data science to deliver patient-level analytics to life sciences companies, payers, providers, and other stakeholders. By delivering transparency and market intelligence, Komodo Health supports decision-making aimed at closing care gaps, reducing disease burden, and enabling more value-driven care. The company was founded in 2014 and is headquartered in New York with an additional office in San Francisco.

FidoCure develops AI-driven precision medicine for canine cancer. It analyzes data from naturally occurring canine tumors using next-generation sequencing and clinical information to build a proprietary learning database for cancer analysis. The company provides genomic sequencing services and targeted therapy recommendations to veterinarians, enabling personalized treatment plans. By linking veterinary and human oncology, FidoCure advances comparative oncology, aims to improve outcomes for dogs and to inform drug development that benefits both pets and people.

Accolade, Inc. is a technology-driven company that provides personalized health and benefits solutions designed to enhance the healthcare experience for employees and their families in the United States. Founded in 2007 and headquartered in Plymouth Meeting, Pennsylvania, Accolade offers a comprehensive platform that combines cloud-based technology with support from a team of health assistants and clinicians, including nurses and behavioral health specialists. The company's services help employers navigate the complexities of the healthcare system and workplace benefits, ultimately aiming to improve health outcomes and reduce costs. By focusing on healthcare process improvement and employee engagement, Accolade delivers tailored advocacy to meet the specific needs of its clients.

Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

Deepcell, Inc. is a biotechnology company based in Mountain View, California, that specializes in single-cell analysis technology. Founded in 2015, the company has developed an AI-powered imaging and microfluidics platform that offers a non-invasive method for genetic testing with diagnostic-level accuracy. This platform enables researchers to classify and isolate viable cells based on their morphological characteristics, thus facilitating improved diagnosis and treatment of diseases. By providing detailed genetic health information through ordinary blood samples, Deepcell aims to enhance translational research, diagnostic testing, and therapeutic applications, ultimately reducing the need for invasive procedures in medical diagnostics.

TL Biolabs Corp., established in 2016 and headquartered in Santa Clara, California, specializes in providing automated genomic testing services for the livestock industry, focusing on beef and dairy cattle. The company offers affordable genomic tests along with complimentary software to deliver practical insights from test results.

Shield Bio is a biotechnology company focused on combating antibiotic resistance, a growing public health crisis projected to surpass cancer-related deaths by 2050. The company has developed a novel genomic testing platform that enables sexually transmitted infection (STI) clinics to accurately identify antibiotic-resistant strains of pathogens, particularly gonorrhea, which has shown resistance to multiple antibiotics. With approximately 820,000 new gonorrhea infections annually in the United States and the Centers for Disease Control and Prevention designating resistant strains as an urgent threat, Shield Bio's rapid and precise molecular antibiotic susceptibility testing is critical. This platform allows healthcare providers to determine the most effective antibiotics for treatment, thereby enhancing patient outcomes and helping to curb the spread of antibiotic resistance.

Jungla Inc., established in 2016 and headquartered in South San Francisco, is a biotechnology company specializing in molecular function software for healthcare and pharmaceutical industries. It optimizes disease diagnosis by developing advanced functional genomics, computational biophysics, and computer science technologies. Jungla's platform proactively assesses genetic variant risks, providing quantitative insights to complement observational data. This enhances clinical genetic testing accuracy and delivers robust, scalable results. As of July 2019, Jungla operates as a subsidiary of Invitae Corporation.

Cardiogram, Inc. is a San Francisco-based company founded in 2015 that specializes in developing a wearable device for monitoring heart health. The company's application allows users to analyze and visualize their heart rate measurements, tracking responses to various activities such as exercise, stress, and dietary changes. By detecting heartbeats and monitoring sleep and fitness patterns, Cardiogram aims to empower users to prevent serious cardiovascular issues, including strokes. The application is compatible with devices equipped with heart rate monitors, such as the Apple Watch and Android Wear, and facilitates the sharing of heart rate data through various social media platforms.

Accolade, Inc. is a technology-driven company that provides personalized health and benefits solutions designed to enhance the healthcare experience for employees and their families in the United States. Founded in 2007 and headquartered in Plymouth Meeting, Pennsylvania, Accolade offers a comprehensive platform that combines cloud-based technology with support from a team of health assistants and clinicians, including nurses and behavioral health specialists. The company's services help employers navigate the complexities of the healthcare system and workplace benefits, ultimately aiming to improve health outcomes and reduce costs. By focusing on healthcare process improvement and employee engagement, Accolade delivers tailored advocacy to meet the specific needs of its clients.

Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

Glow, Inc. is a company focused on women's health, particularly in the areas of fertility, pregnancy, and reproductive well-being. Founded in 2013 and based in San Francisco, it develops and operates mobile applications designed to offer information and support throughout various phases of women's reproductive health. Its primary offerings include Ruby By Glow, which provides period and ovulation tracking alongside health and sex education; Glow, an ovulation calculator; and Glow Nurture, a pregnancy tracking solution. Additionally, Glow offers a community fund program aimed at making infertility treatment more accessible through collective risk pooling among couples. This non-profit initiative also provides financial assistance to accredited infertility clinics for couples who do not achieve pregnancy. Glow's applications utilize data analysis to help users track their cycles and enhance fertility outcomes, offering resources and support for those experiencing pregnancy loss as well.

uBiome, Inc. was a microbial genomics company based in San Francisco, California, founded in 2012. It specialized in sequencing-based clinical microbiome tests, offering products such as SmartGut, a test for identifying pathogenic and commensal microorganisms related to infections, and SmartJane, a women's health screening test that detects various conditions including HPV and STIs. The company also provided Explorer kits for citizen scientists and researchers, as well as SmartFlu, a clinical respiratory test. By leveraging precision sequencing combined with machine learning and artificial intelligence, uBiome aimed to enhance the understanding of the human microbiome, enabling healthcare providers to deliver more accurate diagnoses and empowering patients to manage their health more effectively. However, uBiome faced financial difficulties and filed for Chapter 11 bankruptcy in September 2019, which was later converted to Chapter 7 on October 11, 2019.

SolveBio is a contextual knowledge hub that specializes in genomic intelligence, aimed at supporting pharmaceutical, biotechnology, and diagnostic organizations. The company offers a platform designed to manage, distribute, and access genomic reference data at scale, facilitating the integration of both external and internal genomic information. This platform enables clients to leverage valuable third-party data assets, thereby driving innovation in precision medicine and advancing human health. By providing a real-time dynamic interface, SolveBio empowers organizations to effectively utilize genomic information in their research and development efforts.

Glow, Inc. is a company focused on women's health, particularly in the areas of fertility, pregnancy, and reproductive well-being. Founded in 2013 and based in San Francisco, it develops and operates mobile applications designed to offer information and support throughout various phases of women's reproductive health. Its primary offerings include Ruby By Glow, which provides period and ovulation tracking alongside health and sex education; Glow, an ovulation calculator; and Glow Nurture, a pregnancy tracking solution. Additionally, Glow offers a community fund program aimed at making infertility treatment more accessible through collective risk pooling among couples. This non-profit initiative also provides financial assistance to accredited infertility clinics for couples who do not achieve pregnancy. Glow's applications utilize data analysis to help users track their cycles and enhance fertility outcomes, offering resources and support for those experiencing pregnancy loss as well.

CrowdMed, Inc. is a San Francisco-based company that leverages a prediction market technology to assist in diagnosing complex medical conditions. Founded in 2012, CrowdMed aims to provide patients with streamlined access to diagnostic information for their undiagnosed and chronic symptoms. The company's platform connects patients with a diverse network of medical detectives, including licensed physicians, medical students, and other healthcare professionals, who collaborate to generate diagnostic suggestions. By harnessing the collective intelligence of these experts, CrowdMed offers a collaborative solution for individuals facing unresolved medical issues, ultimately aiming to reduce healthcare costs while maintaining quality care. The platform is designed to empower patients by providing them with insightful answers to their medical challenges through the speed and convenience of online interaction.

Inductive Bio develops a machine learning platform that accelerates compound optimization for pharmaceutical research. It focuses on building datasets and ML models to predict absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of small molecules, enabling scientists to optimize initial compounds into leads and development candidates more efficiently.

Sprinter Health is a mobile healthcare provider that sends full-time nurses and phlebotomists to patients' homes for preventive care services.